{'fraction_non_alphanumeric': 0.023255813953488372, 'fraction_numerical': 0.0, 'mean_word_length': 4.442105263157894, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
FDA approves an AIDS drug from Vertex. Food and Drug Administration.


 The U.S. Food and Drug Administration has granted marketing authorization to Vertex Pharmaceuticals for Agenerase. Agenerase is the fifth drug targeting HIV's protease enzyme that has been approved to treat AIDS. It is only taken twice a day, as opposed to other approved protease drugs which are taken three times a day. However, patients will take eight Agenerase pills at each sitting, rather than two to six pills for other protease drugs.
